GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (OTCPK:CLVSF) » Definitions » Gross-Profit-to-Asset %

CellaVision AB (CellaVision AB) Gross-Profit-to-Asset % : 46.77% (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is CellaVision AB Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. CellaVision AB's annualized Gross Profit for the quarter that ended in Mar. 2024 was $43.06 Mil. CellaVision AB's average Total Assets over the quarter that ended in Mar. 2024 was $92.05 Mil. Therefore, CellaVision AB's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 46.77%.


CellaVision AB Gross-Profit-to-Asset % Historical Data

The historical data trend for CellaVision AB's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellaVision AB Gross-Profit-to-Asset % Chart

CellaVision AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 65.32 50.61 50.58 47.80 51.16

CellaVision AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.12 52.23 49.01 61.91 46.77

Competitive Comparison of CellaVision AB's Gross-Profit-to-Asset %

For the Medical Devices subindustry, CellaVision AB's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellaVision AB's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CellaVision AB's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where CellaVision AB's Gross-Profit-to-Asset % falls into.



CellaVision AB Gross-Profit-to-Asset % Calculation

CellaVision AB's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=45.141/( (85.927+90.539)/ 2 )
=45.141/88.233
=51.16 %

CellaVision AB's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=43.056/( (90.539+93.563)/ 2 )
=43.056/92.051
=46.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


CellaVision AB Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of CellaVision AB's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


CellaVision AB (CellaVision AB) Business Description

Traded in Other Exchanges
Address
Mobilvagen 12, Lund, SWE, 22362
CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers.

CellaVision AB (CellaVision AB) Headlines

From GuruFocus

3 Scandinavian Companies With Strong Margin Growth

By James Li James Li 12-01-2020